Market closed
Rezolute/$RZLT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Rezolute
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.
Ticker
$RZLT
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
64
ISIN
US76200L3096
Website
Rezolute Metrics
BasicAdvanced
$224M
-
-$1.17
1.10
-
Price and volume
Market cap
$224M
Beta
1.1
52-week high
$6.10
52-week low
$2.22
Average daily volume
1.4M
Financial strength
Current ratio
9.304
Quick ratio
9.101
Long term debt to equity
1.339
Total debt to equity
1.94
Management effectiveness
Return on assets (TTM)
-42.81%
Return on equity (TTM)
-74.36%
Valuation
Price to book
2.25
Price to tangible book (TTM)
2.25
Price to free cash flow (TTM)
-3.539
Growth
Earnings per share change (TTM)
6.04%
3-year earnings per share growth (CAGR)
-26.80%
What the Analysts think about Rezolute
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Rezolute stock.
Rezolute Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Rezolute Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Rezolute News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Rezolute stock?
Rezolute (RZLT) has a market cap of $224M as of May 11, 2025.
What is the P/E ratio for Rezolute stock?
The price to earnings (P/E) ratio for Rezolute (RZLT) stock is 0 as of May 11, 2025.
Does Rezolute stock pay dividends?
No, Rezolute (RZLT) stock does not pay dividends to its shareholders as of May 11, 2025.
When is the next Rezolute dividend payment date?
Rezolute (RZLT) stock does not pay dividends to its shareholders.
What is the beta indicator for Rezolute?
Rezolute (RZLT) has a beta rating of 1.1. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.